LFCR
Lifecore Biomedical Inc.
4.40$
-2.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.9% | 86.9% | 84.4% | 85.1% | 85.5% | 75.4% | 61.4% | 72.9% | 64.9% | 67.4% | 68.7% | 68.6% | |
| 12.1% | 13.1% | 15.6% | 14.9% | 14.5% | 24.6% | 38.6% | 27.1% | 35.1% | 32.6% | 31.3% | 31.4% | |
| 1.3% | 1.3% | 1.8% | 2.4% | 2.1% | 4.7% | 6.6% | 4.2% | 7.0% | 6.7% | 6.4% | 6.6% | |
| – | 8.8% | 10.6% | 9.6% | 11.3% | 45.0% | 64.7% | 24.8% | 38.1% | 33.5% | 34.2% | – | |
| 8.7% | 10.5% | 12.7% | 12.4% | 13.5% | 40.8% | 47.3% | 29.0% | 45.7% | 39.5% | 44.7% | 32.3% | |
| 3.4% | -3.7% | 2.9% | 2.3% | -1.4% | -16.2% | -8.7% | -1.9% | -10.6% | -6.9% | -13.4% | -1.0% | |
| 0.3% | 0.4% | 0.3% | 0.4% | 0.9% | 2.9% | 8.9% | 9.3% | 14.0% | 14.1% | 16.9% | 1.7% | |
| 4.0% | -3.5% | 2.8% | 3.1% | 0.7% | -19.1% | -29.5% | -28.1% | -18.6% | 7.4% | -30.0% | -23.3% | |
| 1.4% | -1.4% | 0.8% | -1.8% | 0.3% | -5.5% | -6.3% | -3.1% | -4.7% | 0.1% | 0.0% | 0.4% | |
| 2.5% | -2.2% | 2.0% | 4.7% | 0.4% | -23.9% | -32.0% | -52.4% | -104.9% | 9.4% | -30.0% | -23.8% | |
| 5.6% | -1.4% | 5.0% | 4.8% | 4.2% | -4.5% | -1.0% | -36.6% | 11.5% | 27.8% | -6.8% | 6.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.